BRPI0418980A - método e aparelho para analisar fluido amniótico - Google Patents

método e aparelho para analisar fluido amniótico

Info

Publication number
BRPI0418980A
BRPI0418980A BRPI0418980-9A BRPI0418980A BRPI0418980A BR PI0418980 A BRPI0418980 A BR PI0418980A BR PI0418980 A BRPI0418980 A BR PI0418980A BR PI0418980 A BRPI0418980 A BR PI0418980A
Authority
BR
Brazil
Prior art keywords
amniotic fluid
spectra
monitoring
baby
analyzing
Prior art date
Application number
BRPI0418980-9A
Other languages
English (en)
Inventor
Kristine G Koski
David H Burns
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Publication of BRPI0418980A publication Critical patent/BRPI0418980A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Abstract

MéTODO E APARELHO PARA ANALISAR FLUIDO AMNIóTICO. São fornecidos métodos e espectros para monitorar o crescimento fetal e prever o peso de nascimento de um bebê antes do nascimento em que um ou mais dos marcadores biológicos selecionados são medidos em uma amostra de fluido amniótico obtida a partir de uma mulher grávida. Os níveis dos marcadores bioquímicas e/ou dos espectros selecionados são correlacionados com uma ou mais condições médicas, tais como o crescimento fetal e o peso do nascimento de um bebê, e diabetes gestacional. Uma sonda de medida para a medição in situ pode ser usada com segurança e repetidamente. O monitoramento e/ou o tratamento da saúde materna ou fetal também é fornecido.
BRPI0418980-9A 2003-08-21 2004-08-21 método e aparelho para analisar fluido amniótico BRPI0418980A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49688403P 2003-08-21 2003-08-21
PCT/IB2004/002720 WO2005019792A2 (en) 2003-08-21 2004-08-21 Method and apparatus for analyzing amniotic fluid

Publications (1)

Publication Number Publication Date
BRPI0418980A true BRPI0418980A (pt) 2007-12-11

Family

ID=34216047

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418980-9A BRPI0418980A (pt) 2003-08-21 2004-08-21 método e aparelho para analisar fluido amniótico

Country Status (5)

Country Link
US (1) US8165661B2 (pt)
EP (1) EP1658484A4 (pt)
BR (1) BRPI0418980A (pt)
CA (1) CA2577587A1 (pt)
WO (1) WO2005019792A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5451607B2 (ja) * 2007-06-28 2014-03-26 リバー ダイアグノスティックス ベー．フェー． 突然変異の可能性を判定する方法
JP6144916B2 (ja) * 2012-01-30 2017-06-07 キヤノン株式会社 生体組織画像のノイズ低減処理方法及び装置
US9766126B2 (en) 2013-07-12 2017-09-19 Zyomed Corp. Dynamic radially controlled light input to a noninvasive analyzer apparatus and method of use thereof
TWI598577B (zh) * 2014-03-28 2017-09-11 Metallogenics Co Ltd Method for obtaining data for determining possibility of carcinogenesis of endometriotic ovarian cysts, and diagnostic apparatus thereof
US10542961B2 (en) 2015-06-15 2020-01-28 The Research Foundation For The State University Of New York System and method for infrasonic cardiac monitoring
JP7097570B2 (ja) * 2018-08-27 2022-07-08 株式会社Ｎｔｔドコモ データ収集解析装置及びデータ収集解析方法
NL2030042B1 (en) * 2021-12-06 2023-06-22 Univ Eindhoven Tech A method and sensor system for characterizing in vivo the concentration of a compound in amniotic fluid

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215398A (ja) 1986-01-06 1987-09-22 アイソラブ，インク． 医療診断用指示要素として羊水中のホスフアチジルグリセロ−ルの量を測定する方法とそのキツト
WO1988002616A1 (en) 1986-10-08 1988-04-21 St. Mary's Hospital Medical School Intrauterine probe
KR100213554B1 (ko) * 1989-11-28 1999-08-02 제이슨 오토 가도시 태아용 탐침
US5172693A (en) * 1990-01-16 1992-12-22 Doody Michael C Prenatal non-invasive detection of meconium stained amniotic fluid
GB9014786D0 (en) 1990-07-04 1990-08-22 Imperial College Meconium monitoring system
GB2269007B (en) 1992-07-01 1996-03-27 Imperial College Monitoring of the condition of a foetus during labour
JPH05203644A (ja) 1992-01-28 1993-08-10 Otsuka Pharmaceut Co Ltd 胎便成分の測定方法
US5235985A (en) * 1992-04-30 1993-08-17 Mcmorrow Gerald J Automatic bladder scanning apparatus
US5425362A (en) 1993-07-30 1995-06-20 Criticare Fetal sensor device
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
US5839439A (en) * 1995-11-13 1998-11-24 Nellcor Puritan Bennett Incorporated Oximeter sensor with rigid inner housing and pliable overmold
US5713351A (en) 1995-11-20 1998-02-03 Utah Medical Products, Inc. Intrauterine meconium detection system
EP1054620B1 (en) 1998-02-13 2010-01-27 Non-Invasive Technology, Inc. Transabdominal examination, monitoring and imaging of tissue
US6044284A (en) 1998-10-08 2000-03-28 Leonard I. Eisenfeld Apparatus and method for measuring the concentration of meconium in amniotic fluid
US6618138B2 (en) * 2000-10-12 2003-09-09 Jed Khoury Scanning fluorescent systems for various diagnostic
GB0031566D0 (en) * 2000-12-22 2001-02-07 Mets Ometrix Methods for spectral analysis and their applications
US7524681B2 (en) 2001-01-22 2009-04-28 Andreas Wolf Rapid assay for biological substances using FTIR
JP2003144439A (ja) 2001-11-09 2003-05-20 Japan Science & Technology Corp 光学的手法を用いた子宮内酸素動態の測定方法とその装置
WO2003076589A2 (en) * 2002-03-08 2003-09-18 Kopreski Michael S Analysis of apoptotic bodies in bodily fluids
US6690958B1 (en) * 2002-05-07 2004-02-10 Nostix Llc Ultrasound-guided near infrared spectrophotometer
US7041059B2 (en) * 2002-08-02 2006-05-09 Diagnostic Ultrasound Corporation 3D ultrasound-based instrument for non-invasive measurement of amniotic fluid volume
JP3883001B2 (ja) 2002-10-07 2007-02-21 国立循環器病センター総長 子宮内埋め込み型胎児モニタリング装置
US6695780B1 (en) 2002-10-17 2004-02-24 Gerard Georges Nahum Methods, systems, and computer program products for estimating fetal weight at birth and risk of macrosomia
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7399278B1 (en) * 2003-05-05 2008-07-15 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Method and system for measuring amniotic fluid volume and/or assessing fetal weight
IL164030A0 (en) * 2003-09-12 2005-12-18 Revital Pery Shechter Photoacoustic analyzer of a region of interest in a human body
JP2007504883A (ja) 2003-09-12 2007-03-08 オル−ニム メディカル リミテッド 対象領域の非侵襲的光学モニタリング
CA2539430C (en) 2003-09-23 2015-03-17 The General Hospital Corporation Screening for gestational disorders with sex hormone binding globulin as biomarker

Also Published As

Publication number Publication date
WO2005019792A2 (en) 2005-03-03
EP1658484A2 (en) 2006-05-24
US20060247536A1 (en) 2006-11-02
CA2577587A1 (en) 2005-03-03
WO2005019792A3 (en) 2006-03-23
EP1658484A4 (en) 2008-05-14
US8165661B2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
Vandiver et al. Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin
Sprague et al. Circulating serum xenoestrogens and mammographic breast density
Pasqualotto et al. Semen quality and oxidative stress scores in fertile and infertile patients with varicocele
Lavery et al. The utility of venous lactate to triage injured patients in the trauma center
Barazani et al. Functional sperm testing and the role of proteomics in the evaluation of male infertility
BRPI0408950A (pt) método para determinar a situação de doença de um paciente, e, método para selecionar um paciente para tratamento de um cáncer com um ou mais medicamentos de ação dimérica
DE602007008224D1 (de) Vorhersage von letalität und detektion von schweren erkrankungen
AR034379A1 (es) Dispositivo de muestreo percutaneo de fluidos biologicos y de medicion de analitas
Kankaanpää et al. Leisure-time and occupational physical activity associates differently with epigenetic aging
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BRPI0815857A2 (pt) "método para testar a eficácia biocida de agentes biocidas contra anaeróbios"
WO2011123775A3 (en) Methods, systems, and devices for analizing patient data
BR112022007996A2 (pt) Métodos para o tratamento e uso de biomarcadores para predizer a sensibilidade clínica à 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida
Hejl et al. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis
BRPI0418980A (pt) método e aparelho para analisar fluido amniótico
Zaki et al. Testing the agreement of medical instruments: Overestimation of bias in the Bland–Altman analysis
van Horssen et al. Lactate point-of-care testing for acidosis: cross-comparison of two devices with routine laboratory results
Nordström et al. Fetal scalp and umbilical artery blood lactate measured with a new test strip method
Hall et al. A pilot study to determine the feasibility of collecting amniotic fluid samples from women during labour and measuring amniotic fluid lactate at point of care
Mitchell et al. Estimation of lean body weight in older women with hip fracture
Sauer et al. Research Note: Comparison of chicken blood chemistry and electrolyte parameters between the portable i-STAT1 clinical analyzer and VetScan VS2 serum biochemistry panel using Hy-Line commercial white-egg laying hens
Çevik et al. The role of urine trypsinogen-2 test in the differential diagnosis of acute pancreatitis in the Emergency Department
Ju et al. Plasma cell‐free DNA analysis for COVID‐19 and beyond
Boteju et al. Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
Tiligada et al. Histamine quantification in human blood samples

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 8A ANUIDADE.